Bone marrow mesenchymal stem cell exosomes in osteonecrosis: pathological mechanisms and therapeutic strategies.
Yuele M., Yan W., Hongwei C., Hui Z., Guang L., Yanxin L.
Narrative Review on Face & Skin, published in Mol Biol Rep (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Mol Biol Rep (2026)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42550377
- DOI
- 10.1007/s11033-026-12513-3
Abstract (original English)
Osteonecrosis is bone death caused by disrupted blood supply. It often leads to bone collapse and joint failure. Current treatments ease symptoms but cannot reverse dead bone tissue. They also have high recurrence rates. Bone marrow-derived mesenchymal stem cell exosomes (BMSC-Exos) are natural carriers. They mediate cell communication. Preclinical studies suggest they modulate osteoclast and osteoblast activity. They may also influence cell death pathways. But direct evidence in human osteonecrosis remains limited. BMSC-Exos have safety and immune compatibility advantages over conventional cell therapies in animal models. Yet clinical application faces major barriers. Existing reviews have not fully addressed them. Recent reviews treat mesenchymal stem cell exosomes(MSC-Exos) from different sources as the same. They discuss osteonecrosis as a uniform target. They overlook lesion zones, source-specific bone-forming bias, and production barriers. This review examines the gap between preclinical findings and clinical use. It focuses on three areas: (1) spatial variation of necrotic lesions and delivery needs; (2) the bone marrow niche advantage of BMSC-Exos versus adipose-derived stem cells(ADSC-) or umbilical cord-derived(UC-) MSC-Exos; and (3) unresolved barriers in standardized production, potency testing, and stage-specific strategy validation.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Oncologic safety of autologous fat grafting in head and neck cancer patients: A scoping review.
Systematic Review with a reported sample of 116 on Face & Skin, published in Med Oral Patol Oral Cir Bucal (2026) — summary generated from the PubMed abstract.
- 2026
- n = 116
Med Oral Patol Oral Cir Bucal - Level ASystematic ReviewEurope PMC
Stem cell-derived exosomes in tissue regeneration of oral and maxillofacial region: A systematic review
Systematic Review on Chronic Wound, published in Medicine (Baltimore) (2026) — summary generated from the PubMed abstract.
- 2026
Medicine (Baltimore) - Level AMeta-analysisPubMed
Stromal Vascular Fraction-Assisted Fat Grafting: A Systematic Review and Meta-analysis of Clinical Outcomes.
Meta-analysis on Face & Skin, published in Aesthetic Plast Surg (2026) — summary generated from the PubMed abstract.
- 2026
Aesthetic Plast Surg - Level ASystematic ReviewEurope PMC
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives
Systematic Review on Face & Skin, Systemic / IV, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci2 citations - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Osteogenic and Biocompatibility Potential of Polylactic Acid-Based Materials: A Systematic Review of Human Primary Cells Studies
Systematic Review on Face & Skin, published in J Funct Biomater (2026) — summary generated from the PubMed abstract.
- 2026
J Funct Biomater